As of January 22, 2025, Fulcrum Therapeutics (FULC) has a market cap of $0.22 billion USD. According to our data, Fulcrum Therapeutics is ranked No.7013 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.22 B |
-12.98%
|
Dec 31, 2024 | $0.25 B |
-30.37%
|
Dec 29, 2023 | $0.36 B |
-7.28%
|
Dec 30, 2022 | $0.39 B |
-58.85%
|
Dec 31, 2021 | $0.95 B |
51.07%
|
Dec 31, 2020 | $0.63 B |
-29.63%
|
Dec 31, 2019 | $0.90 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
Avidity Biosciences
RNA
|
$3.59 B |
-0.000 M
|
USA
|
Wave Life Sciences
WVE
|
$1.78 B |
0.000 M
|
Singapore
|
Solid Biosciences
SLDB
|
$0.12 B |
-0.000 M
|
USA
|
BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
PTC Therapeutics
PTCT
|
$3.48 B |
-0.000 M
|
USA
|
Ultragenyx
RARE
|
$3.97 B |
0.000 M
|
USA
|
Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
Market Cap | = | FULC Stock Price | * | FULC Shares Outstanding |
= | $4.09 | * | 53.94 M | |
= | $0.22 B |